Skip to main content
    • Aa
    • Aa

Cost-Effectiveness of Preoperative Nasal Mupirocin Treatment in Preventing Surgical Site Infection in Patients Undergoing Total Hip and Knee Arthroplasty: A Cost-Effectiveness Analysis

  • Xan F. Courville (a1) (a2), Ivan M. Tomek (a1), Kathryn B. Kirkland (a3) (a2), Marian Birhle (a2), Stephen R. Kantor (a1) and Samuel R. G. Finlayson (a4) (a2)...

To perform a cost-effectiveness analysis to evaluate preoperative use of mupirocin in patients with total joint arthroplasty (TJA).


Simple decision tree model.


Outpatient TJA clinical setting.


Hypothetical cohort of patients with TJA.


A simple decision tree model compared 3 strategies in a hypothetical cohort of patients with TJA: (1) obtaining preoperative screening cultures for all patients, followed by administration of mupirocin to patients with cultures positive for Staphylococcus aureus; (2) providing empirical preoperative treatment with mupirocin for all patients without screening; and (3) providing no preoperative treatment or screening. We assessed the costs and benefits over a 1-year period. Data inputs were obtained from a literature review and from our institution's internal data. Utilities were measured in quality-adjusted life-years, and costs were measured in 2005 US dollars.

Main Outcome Measure.

Incremental cost-effectiveness ratio.


The treat-all and screen-and-treat strategies both had lower costs and greater benefits, compared with the no-treatment strategy. Sensitivity analysis revealed that this result is stable even if the cost of mupirocin was over $100 and the cost of SSI ranged between $26,000 and $250,000. Treating all patients remains the best strategy when the prevalence of S. aureus carriers and surgical site infection is varied across plausible values as well as when the prevalence of mupirocin-resistant strains is high.


Empirical treatment with mupirocin ointment or use of a screen-and-treat strategy before TJA is performed is a simple, safe, and cost-effective intervention that can reduce the risk of SSI. S. aureus decolonization with nasal mupirocin for patients undergoing TJA should be considered.

Level of Evidence.

Level II, economic and decision analysis.

Infect Control Hosp Epidemiol 2012;33(2):152-159

Corresponding author
Department of Orthopaedics, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756 (
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

5.NF SooHoo , JR Lieberman , CY Ko , DS Zingmond . Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am 2006;88(3):480485.

6.SM Kurtz , KL Ong , E Lau , KJ Bozic , D Berry , J Parvizi . Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010;468:5256.

8.CK Hebert , RE Williams , RS Levy , RL Barrack . Cost of treating an infected total knee replacement. Clin Orthop Relat Res 1996;331:140145.

13.MD Kalmeijer , H Coertijens , PM van Nieuwland-Bollen . Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind randomized, placebo-controlled study. Clin Infect Dis 2002;35:353358.

14.DM Hacek , WJ Robb , SM Paule , JC Kudrna , VP Stamos , LR Peterson . Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008;466(6):13491355.

15.CS Price , A Williams , G Philips , M Dayton , W Smith , S Morgan . Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients. Clin Orthop Relat Res 2008;466(11):28422847.

19.MH Wilcox , J Hall , H Pike , et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54(3):196201.

20.LG Bode , JA Kluytmans , HF Wertheim , et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362(1):917.

25.T Horan , M Andrus , M Dudeck . CDC/NHSN surveillance definition of health care associated infection and criteria for specific types of infections in the acute setting. Am J Infect Control 2008;36:309332.

30.KJ Bozic , P Katz , M Cisternas , L Ono , MD Ries , J Showstack . Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 2005;87:570576.

35.AS Lee , M Macedo-Vinas , P Francois , et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methacillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011;52:14221430.

36.KW McConeghy , DJ Mikolich , KL LaPlante . Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009;29(3):263280.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score